Literature DB >> 24522925

Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation.

Wei Jiang1, Souheil-Antoine Younes, Nicholas T Funderburg, Joseph C Mudd, Enrique Espinosa, Miles P Davenport, Denise C Babineau, Scott F Sieg, Michael M Lederman.   

Abstract

UNLABELLED: The mechanisms of increased memory CD4+ T cell cycling in HIV disease are incompletely understood but have been linked to antigen stimulation, homeostatic signals, or exposure to microbial products and the inflammatory cytokines that they induce. We examined the phenotype and Vβ family distribution in cycling memory CD4+ T cells among 52 healthy and 59 HIV-positive (HIV+) donors. Cycling memory CD4+ T cells were proportionally more frequent in subjects with HIV infection than in controls, more often expressed CD38 and PD-1, and less frequently expressed OX40 and intracellular CD40L. OX40 expression on memory CD4+ T cells was induced in vitro by anti-CD3, interleukin-2 (IL-2), IL-7, or IL-15 but not by Toll-like receptor ligands. In HIV+ donors, memory CD4+ T cell cycling was directly related to plasma lipopolysaccharide (LPS) levels, to plasma HIV RNA levels, and to memory CD8+ T cell cycling and was inversely related to peripheral blood CD4+ T cell counts but not to the levels of IL-2, IL-7, or IL-15, while in HIV-negative donors, memory CD4+ T cell cycling was related to IL-7 levels and negatively related to the plasma levels of LPS. In both controls and HIV+ donors, cycling memory CD4+ T cells had a broad distribution of Vβ families comparable to that of noncycling cells. Increased memory CD4+ T cell cycling in HIV disease is reflective of generalized immune activation and not driven primarily by cognate peptide stimulation or exposure to common gamma-chain cytokines. This cycling may be a consequence of exposure to microbial products, to plasma viremia, or, otherwise, to proinflammatory cytokines. IMPORTANCE: This work provides evidence that the increased memory CD4+ T cell cycling in HIV infection is not a result of cognate peptide recognition but, rather, is more likely related to the inflammatory environment of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522925      PMCID: PMC4019138          DOI: 10.1128/JVI.00017-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Dissociation of CD154 and cytokine expression patterns in CD38+ CD4+ memory T cells in chronic HIV-1 infection.

Authors:  Enrique Espinosa; Christopher E Ormsby; Gustavo Reyes-Terán; Robert Asaad; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

2.  High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).

Authors:  John J Zaunders; Mee Ling Munier; Nabila Seddiki; Sarah Pett; Susanna Ip; Michelle Bailey; Yin Xu; Kai Brown; Wayne B Dyer; Min Kim; Robert de Rose; Stephen J Kent; Lele Jiang; Samuel N Breit; Sean Emery; Anthony L Cunningham; David A Cooper; Anthony D Kelleher
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

3.  Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.

Authors:  Michael M Lederman; Leonard Calabrese; Nicholas T Funderburg; Brian Clagett; Kathy Medvik; Hector Bonilla; Barbara Gripshover; Robert A Salata; Alan Taege; Michelle Lisgaris; Grace A McComsey; Elizabeth Kirchner; Jane Baum; Carey Shive; Robert Asaad; Robert C Kalayjian; Scott F Sieg; Benigno Rodriguez
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

4.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

5.  Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.

Authors:  Shu-Ye Zhang; Zheng Zhang; Jun-Liang Fu; Fu-Biao Kang; Xiang-Sheng Xu; Wei-Min Nie; Chun-Bao Zhou; Min Zhao; Fu-Sheng Wang
Journal:  Eur J Immunol       Date:  2009-05       Impact factor: 5.532

6.  Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys.

Authors:  Shari N Gordon; Nichole R Klatt; Steven E Bosinger; Jason M Brenchley; Jeffrey M Milush; Jessica C Engram; Richard M Dunham; Mirko Paiardini; Sara Klucking; Ali Danesh; Elizabeth A Strobert; Cristian Apetrei; Ivona V Pandrea; David Kelvin; Daniel C Douek; Silvija I Staprans; Donald L Sodora; Guido Silvestri
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort.

Authors:  Damalie Nakanjako; Isaac Ssewanyana; Harriet Mayanja-Kizza; Agnes Kiragga; Robert Colebunders; Yukari C Manabe; Rose Nabatanzi; Moses R Kamya; Huyen Cao
Journal:  BMC Infect Dis       Date:  2011-02-08       Impact factor: 3.090

8.  SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection.

Authors:  Constantinos Petrovas; David A Price; Joseph Mattapallil; David R Ambrozak; Christof Geldmacher; Valentina Cecchinato; Monica Vaccari; Elzbieta Tryniszewska; Emma Gostick; Mario Roederer; Daniel C Douek; Sara H Morgan; Simon J Davis; Genoveffa Franchini; Richard A Koup
Journal:  Blood       Date:  2007-04-17       Impact factor: 22.113

9.  Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.

Authors:  Nicholas Funderburg; Angel A Luciano; Wei Jiang; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

10.  HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation.

Authors:  Adriano Boasso; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Gene M Shearer
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

View more
  20 in total

1.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

2.  A protocol for quantizing total bacterial 16S rDNA in plasma as a marker of microbial translocation in vivo.

Authors:  Wei Jiang
Journal:  Cell Mol Immunol       Date:  2018-04-16       Impact factor: 11.530

3.  Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection.

Authors:  M-A Jenabian; M Patel; I Kema; K Vyboh; C Kanagaratham; D Radzioch; P Thébault; R Lapointe; N Gilmore; P Ancuta; C Tremblay; J-P Routy
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

4.  The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.

Authors:  Anna M Powell; Zhenwu Luo; Lisa Martin; Zhuang Wan; Lei Ma; Guoyang Liao; Yuxia Song; Xiaochun Li; J Michael Kilby; Lei Huang; Wei Jiang
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

5.  Inflammation Perturbs the IL-7 Axis, Promoting Senescence and Exhaustion that Broadly Characterize Immune Failure in Treated HIV Infection.

Authors:  Carey L Shive; Brian Clagett; Marie R McCausland; Joseph C Mudd; Nicholas T Funderburg; Michael L Freeman; Souheil-Antoine Younes; Brian M Ferrari; Benigno Rodriguez; Grace A McComsey; Leonard H Calabrese; Scott F Sieg; Michael M Lederman
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-15       Impact factor: 3.731

6.  A link between IL-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.

Authors:  Zhenwu Luo; Min Li; Fuli Mi; Zhefeng Meng; Guoqiang Du; Lisa Martin; Hui Liu; Ping Jin; David Stroncek; Sonya L Heath; Wei Jiang
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

7.  PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients.

Authors:  Julien Pothlichet; Thierry Rose; Florence Bugault; Louise Jeammet; Annalisa Meola; Ahmed Haouz; Frederick Saul; David Geny; José Alcami; Ezequiel Ruiz-Mateos; Luc Teyton; Gérard Lambeau; Jacques Thèze
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

8.  Distinct activation thresholds of human conventional and innate-like memory T cells.

Authors:  Chloe K Slichter; Andrew McDavid; Hannah W Miller; Greg Finak; Brenda J Seymour; John P McNevin; Gabriela Diaz; Julie L Czartoski; M Juliana McElrath; Raphael Gottardo; Martin Prlic
Journal:  JCI Insight       Date:  2016-06-02

9.  Drug Use is Associated with Anti-CD4 IgG-mediated CD4+ T Cell Death and Poor CD4+ T Cell Recovery in Viral-suppressive HIV-infected Individuals Under Antiretroviral Therapy.

Authors:  Wei Jiang; Zhenwu Luo; Lisa Martin; Zhuang Wan; Pingfu Fu; Amanda Wagner; Binhua Ling; Sonya L Heath; Azizul Haque; Aimee McRae-Clark
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

10.  Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction.

Authors:  Souheil-Antoine Younes; Aarthi Talla; Susan Pereira Ribeiro; Evgeniya V Saidakova; Larisa B Korolevskaya; Konstantin V Shmagel; Carey L Shive; Michael L Freeman; Soumya Panigrahi; Sophia Zweig; Robert Balderas; Leonid Margolis; Daniel C Douek; Donald D Anthony; Pushpa Pandiyan; Mark Cameron; Scott F Sieg; Leonard H Calabrese; Benigno Rodriguez; Michael M Lederman
Journal:  J Clin Invest       Date:  2018-10-15       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.